A Phase IV Clinical Trial to Evaluate the Safety and Tolerability of ZOSTAVAX in Subjects 60 Years of Age or Older.

Trial Profile

A Phase IV Clinical Trial to Evaluate the Safety and Tolerability of ZOSTAVAX in Subjects 60 Years of Age or Older.

Completed
Phase of Trial: Phase IV

Latest Information Update: 18 Apr 2017

At a glance

  • Drugs Varicella zoster virus vaccine live (Primary)
  • Indications Herpes zoster
  • Focus Adverse reactions
  • Sponsors Merck Sharp & Dohme
  • Most Recent Events

    • 10 May 2012 Additional locations (Germany, Spain and United Kingdom) added as reported by European Clinical Trials Database record.
    • 13 May 2010 Results were presented at the Annual Scientific Meeting of the American Geriatrics Society (2010).
    • 03 Feb 2010 Actual patient number (11999) added as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top